Managing Editor – Europe
Latest From Tom Gallen
Italian nutraceutical player Stardea has changed hands. Following six years of ownership by Cooper Consumer Health, the business has been acquired by France's EA Pharma which is keen to expand its footprint outside of its home market.
Following a transitional period of 18 months, maximum levels for pyrrolizidine alkaloids in dietary supplements come into force in the EU from 1 July 2022 for new products placed on the market. Pyrrolizidine alkaloids have been under scrutiny in the EU for over a decade as their consumption has been linked to a number of health issues, including liver damage.
Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.
A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.
French natural consumer health specialist Havea looks set to be snapped up by private-equity firm BC Partners, which has set out a plan to step up the company's M&A and digitization activities.
Two novel food applications were recently reviewed by the European Food Safety Authority, with one from Monterey Mushrooms for vitamin D2 mushroom powder approved, and another from Hamari Chemicals for a new source of zinc rejected.